Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: An open-label, pilot study
- 1 September 2009
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 117 (1-2) , 116-119
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Quetiapine augmentation in depressed patients with partial response to antidepressantsHuman Psychopharmacology: Clinical and Experimental, 2008
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology, 2008
- Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive DisorderThe Journal of Clinical Psychiatry, 2007
- Quetiapine augmentation of treatment-resistant depression: a comparison with lithiumCurrent Medical Research and Opinion, 2007
- Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot studyDepression and Anxiety, 2007
- A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depressionDepression and Anxiety, 2006
- Olanzapine/Fluoxetine Combination for Treatment-Resistant DepressionThe Journal of Clinical Psychiatry, 2005
- A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II DepressionAmerican Journal of Psychiatry, 2005
- The Clinical Anxiety Scale: An Instrument Derived from the Hamilton Anxiety ScaleThe British Journal of Psychiatry, 1982
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979